Post-approval studies (Phase 4)Not Yet RecruitingNCT06294015
What this trial is testing
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
Who this might be right for
Corneal EpitheliopathyGlaucomaCorneal Disease+1 more
Université de Sherbrooke 25